Current Concerns – USTR Report and Biodiversity Guidelines
Journal: Indian Drugs (Vol.56, No. 05)Publication Date: 2019-05-28
Abstract
Dr. Gopakumar G. Nair is a Ph.D in Organic Chemistry (1966) from National Chemical Laboratory, Pune (Pune University). He was a Post-Doctoral fellow at IIT Bombay, Powai (1967) before joining the Pharma Industry. He was Director of Bombay Drug House P. Ltd., later Chairman of BDH Industries Ltd. as well as CMD of Bombay Drugs & Pharma Ltd., which was merged with Strides Arcolab Ltd. in 2001. Dr. Nair served IDMA as office bearer for many years from 1972 onwards and was Chairman of various Committees for nearly 4 decades. He was the President of IDMA in 1999/2000. Currently, Dr. Nair is the Chairman of the IPR Committee in IDMA. Having moved into the Intellectual Property field, he was the Dean of IIPS (Institute of Intellectual Property Studies) at Hyderabad in 2001/2002. Later, he set up his own boutique IP firm, Gopakumar Nair Associates, as well as Gnanlex Hermeneutics Pvt. Ltd., having done his L. L. B. from Mumbai University. He is also CEO of Patent Gurukul and President of Bharat Education Society, Kurla, Mumbai, managing many educational institutions in and around Mumbai.
Other Latest Articles
- The Relationship Between Corporate Risk Taking & Ownership Structure With Emphasize on Legal Environment And Business Groups
- The relationship between employment situation and health condition among Young Adults in Iran Economy
- Adoption of the International Financial Reporting Standards (IFRS) for Small and Medium Enterprises -SMES
- The Effect Of Corporate Governance Mechanisms on Disclosure Score of Listed Companies in Tehran Stock Exchange
- A Review of Ownership and Structure of Holdings Required to provide information for Tehran Stock Exchange
Last modified: 2019-08-20 16:25:21